SynBioTherapy: Revolutionizing Biotherapies through Synthetic Biology
Date: November 27th, 2024 Time: 9h to 18h Location: Auditorium of the Learning Planet Institute, 8bis Rue Charles V, 75004 Paris
Why Attend?
Synthetic biology is driving breakthroughs in the field of biotherapies, offering new opportunities to overcome current technological challenges and bottlenecks. Whether you’re a biotherapy expert seeking new tools for your research or a synbio scientist looking to apply your discoveries to medical therapies, this conference is designed for you.
Key Objectives:
Showcasing Innovation: Learn about groundbreaking applications of synthetic biology in biotherapies.
Overcoming Bottlenecks: Engage in discussions about the major challenges in biotherapy and how synbio can provide solutions.
Fostering Collaboration: Build interdisciplinary collaborations between synbio and biotherapy research labs.
Exploring New Methods: Dive into the future of research with biofoundries, harnessing biology to drive innovation.
Who Should Attend?
Biotherapy researchers interested in exploring novel synthetic biology techniques.
Synthetic biology researchers aiming to transition their work into biotherapeutic applications.
List of speakers
Confirmed International Speakers:
Velia Siciliano, Head of Synthetic and Systems Biology for Biomedicine at IIT Naples: Mammalian cell engineering for biomedicine and bioindustry: What do we know and what do we miss?
Filippo Menolascina, Head of the Engineering Biology Center at Edinburgh University: Rethinking therapy design in the age of laboratory automation: The experience of the Edinburgh Genome Foundry.
A session on “Challenges and Bottlenecks in Biotherapy”:
In vivo applications:
Piera Smeriglio, Centre de Recherche en Myologie: Breakthroughs and Barriers in Gene Therapy for Motor Neuron Disorders.
Christelle Monville, ISTEM: A journey through challenges and bottlenecks in the development of stem cell therapies for Retinal diseases.
Implementing Synbio in Biotherapy Approaches:
Franck Perez, Institute Curie : From Cell Biology to Biotherapies : increasing scale to deal with complexity
Stéphane Lemaire, Sorbonne Université & Biofonderie Paris Bioconvergence (Title TBA)
Networking Opportunities and Informal Breaks:
Throughout the day, there will be informal lunch and coffee breaks to foster lively discussions and allow attendees to connect with international experts and peers in the field. This will be a unique opportunity to exchange ideas and explore potential collaborations in a more relaxed setting.
Roundtable Discussions:
Each session will culminate in interactive roundtable discussions with the speakers, offering a unique opportunity for direct exchange and collaboration.
Register Now to be part of this pioneering conference that brings together the worlds of synthetic biology and biotherapies!
About the organizers
This one-day event, co-organized by the DIM BioConvS and the PEPR Biotherapy and Bioproduction, brings together leaders in synthetic biology and biotherapy to explore the intersection of these fields. Generously funded by Genopole, this conference is designed to showcase innovation, foster collaboration, and spark interdisciplinary conversations.
DIM BioConvS is an interdisciplinary network that supports research in synthetic biology, biotherapy, and bioproduction across Ile-de-France. Its mission is to promote cutting-edge scientific collaboration in these fields.
PEPR Biotherapy and Bioproduction is a national program focused on advancing technologies and therapies in the rapidly growing fields of biotherapy and bioproduction.
Scientific committee
This event is organised by members of the DIM BioConvS and PEPR Biothérapies et Bioproduction scientific teams:
Loading... 
